regulation
No description yet: the sentence for this tag has not been written. 14 records carry it: 14 people.
Related tags
14 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Anthony Lawler Head of the Therapeutic Goods Administration and Deputy Secretary, Health Products Regulation Group (since 2023) · Therapeutic Goods Administration Head of Australia's medicines and medical devices regulator, the body that approves cancer drugs for the Australian market. | none | none | leadership, australia | ||
Chris Decker President and Chief Executive Officer · Clinical Data Interchange Standards Consortium Leads CDISC, the non-profit that sets the clinical trial data standards required by FDA and PMDA, including oncology-specific therapeutic area guides. | none | none | leadership, data standards | ||
Emer Cooke Executive Director · European Medicines Agency Executive Director of the European Medicines Agency since November 2020, overseeing EU approval of cancer medicines. | none | none | leadership, drug approval | ||
Gilles Vassal Board member, Oncopolicy · SIOP Europe (European Society for Paediatric Oncology) Gustave Roussy paediatric oncologist and past SIOPE president who leads its oncopolicy work and helped shape European paediatric medicines regulation. | none | none | leadership, clinician-scientist, paediatric oncology | ||
Huang Guo Commissioner, National Medical Products Administration (NMPA), China · National Medical Products Administration / Center for Drug Evaluation Commissioner of China's National Medical Products Administration, the regulator whose Center for Drug Evaluation reviews new cancer drugs for the Chinese market. | none | none | leadership, government | ||
Jean Lessi Director General · Haute Autorité de Santé Director General of the Haute Autorité de Santé, responsible for the agency's operations since January 2024. | none | none | leadership, health technology assessment | ||
Joseph S. Ross Professor of Medicine (General Medicine) and of Public Health (Health Policy) · Yale University Open Data Access (YODA) Project Yale health policy researcher on the YODA Project leadership team, known for work on FDA regulation and trial transparency. | none | none | clinician-scientist, data sharing | ||
Lawrence Tallon Chief Executive · Medicines and Healthcare products Regulatory Agency Chief Executive of the UK Medicines and Healthcare products Regulatory Agency, the body that approves and monitors cancer medicines and devices in the UK. | none | none | leadership | ||
Lionel Collet President of the Collège · Haute Autorité de Santé Physician and former university president who chairs the Haute Autorité de Santé, France's health technology assessment and quality body. | none | none | leadership, health technology assessment | ||
Rajeev Singh Raghuvanshi Drugs Controller General of India, Central Drugs Standard Control Organisation (CDSCO) · Central Drugs Standard Control Organization India's Drugs Controller General, who heads the Central Drugs Standard Control Organisation, the national regulator for medicines, medical devices and clinical trials. | none | none | leadership, government | ||
Shalene Curtis-Micallef Deputy Minister of Health · Health Canada Senior public servant who has led Health Canada as Deputy Minister since January 2026, after serving as Canada's Deputy Minister of Justice. | none | none | leadership, government | ||
Sonja Optendrenk Impartial Chair (Unparteiische Vorsitzende), Gemeinsamer Bundesausschuss · Gemeinsamer Bundesausschuss / IQWiG Impartial chair of Germany's Federal Joint Committee (G-BA), the body that decides which treatments statutory health insurance covers. | none | none | leadership, health technology assessment | ||
Thomas Kaiser Director (Institutsleiter), IQWiG · Gemeinsamer Bundesausschuss / IQWiG Physician who directs IQWiG, the German institute that produces the benefit assessments underpinning cancer drug pricing and coverage decisions. | none | none | leadership, health technology assessment | ||
Yasuhiro Fujiwara Chief Executive · Pharmaceuticals and Medical Devices Agency Medical oncologist who heads Japan's Pharmaceuticals and Medical Devices Agency, the national drug and device regulator. | none | none | leadership, drug development |
